BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, Yun M, Lee SG, Lee PH. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Nutrition 2021;83:111090. [PMID: 33418492 DOI: 10.1016/j.nut.2020.111090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Gu M, Hong Y, Duan R, Zhou J. Association of Trimethylamine N-Oxide with Normal Aging and Neurocognitive Disorders: A Narrative Review. Brain Sciences 2022;12:1203. [DOI: 10.3390/brainsci12091203] [Reference Citation Analysis]
2 Mudimela S, Vishwanath NK, Pillai A, Morales R, Marrelli SP, Barichello T, Giridharan VV. Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders. Drug Discov Today 2022:S1359-6446(22)00304-X. [PMID: 35998800 DOI: 10.1016/j.drudis.2022.08.002] [Reference Citation Analysis]
3 Praveenraj SS, Sonali S, Anand N, Tousif HA, Vichitra C, Kalyan M, Kanna PV, Chandana KA, Shasthara P, Mahalakshmi AM, Yang J, Pandi-perumal SR, Sakharkar MK, Chidambaram SB. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders. Mol Neurobiol. [DOI: 10.1007/s12035-022-02990-5] [Reference Citation Analysis]
4 Zeng J, Wang X, Pan F, Mao Z. The relationship between Parkinson’s disease and gastrointestinal diseases. Front Aging Neurosci 2022;14:955919. [DOI: 10.3389/fnagi.2022.955919] [Reference Citation Analysis]
5 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
6 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ji X, Tian L, Yao S, Han F, Niu S, Qu C. A Systematic Review of Body Fluids Biomarkers Associated With Early Neurological Deterioration Following Acute Ischemic Stroke. Front Aging Neurosci 2022;14:918473. [DOI: 10.3389/fnagi.2022.918473] [Reference Citation Analysis]
9 Kalagi NA, Thota RN, Stojanovski E, Alburikan KA, Garg ML. Association between Plasma Trimethylamine N-Oxide Levels and Type 2 Diabetes: A Case Control Study. Nutrients 2022;14:2093. [PMID: 35631234 DOI: 10.3390/nu14102093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian A. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105780] [Reference Citation Analysis]
11 Zhang H, Chen Y, Wang Z, Xie G, Liu M, Yuan B, Chai H, Wang W, Cheng P. Implications of Gut Microbiota in Neurodegenerative Diseases. Front Immunol 2022;13:785644. [DOI: 10.3389/fimmu.2022.785644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li Y, Kang J, Lee Y, Chung JY, Cho JY. A validated simple LC-MS/MS method for quantifying trimethylamine N-oxide (TMAO) using a surrogate matrix and its clinical application. Transl Clin Pharmacol 2021;29:216-25. [PMID: 35024362 DOI: 10.12793/tcp.2021.29.e19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ahmed H, Leyrolle Q, Koistinen V, Kärkkäinen O, Layé S, Delzenne N, Hanhineva K. Microbiota-derived metabolites as drivers of gut-brain communication. Gut Microbes 2022;14:2102878. [PMID: 35903003 DOI: 10.1080/19490976.2022.2102878] [Reference Citation Analysis]
14 Hoyles L, Pontifex MG, Rodriguez-Ramiro I, Anis-Alavi MA, Jelane KS, Snelling T, Solito E, Fonseca S, Carvalho AL, Carding SR, Müller M, Glen RC, Vauzour D, McArthur S. Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide. Microbiome 2021;9:235. [PMID: 34836554 DOI: 10.1186/s40168-021-01181-z] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
15 Saji N, Tsuduki T, Murotani K, Hisada T, Sugimoto T, Kimura A, Niida S, Toba K, Sakurai T. Relationship between the Japanese-style diet, gut microbiota, and dementia: A cross-sectional study. Nutrition 2021;94:111524. [PMID: 34952361 DOI: 10.1016/j.nut.2021.111524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
16 Romanenko M, Kholin V, Koliada A, Vaiserman A. Nutrition, Gut Microbiota, and Alzheimer's Disease. Front Psychiatry 2021;12:712673. [PMID: 34421687 DOI: 10.3389/fpsyt.2021.712673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]